Pallas Capital Advisors LLC Nuvation Bio Inc. Transaction History
Pallas Capital Advisors LLC
- $2.21 Billion
- Q4 2024
A detailed history of Pallas Capital Advisors LLC transactions in Nuvation Bio Inc. stock. As of the latest transaction made, Pallas Capital Advisors LLC holds 17,016 shares of NUVB stock, worth $43,220. This represents 0.0% of its overall portfolio holdings.
Number of Shares
17,016
Previous 15,934
6.79%
Holding current value
$43,220
Previous $36,000
25.0%
% of portfolio
0.0%
Previous 0.0%
Shares
7 transactions
Others Institutions Holding NUVB
# of Institutions
158Shares Held
157MCall Options Held
3.2KPut Options Held
98.7K-
Decheng Capital LLC Menlo Park, CA26MShares$65.9 Million14.08% of portfolio
-
Eco R1 Capital, LLC San Francisco, CA19.2MShares$48.8 Million1.92% of portfolio
-
Black Rock Inc. New York, NY16.2MShares$41.2 Million0.0% of portfolio
-
Omega Fund Management, LLC Boston, MA13.1MShares$33.2 Million44.61% of portfolio
-
Octagon Capital Advisors LP New York, NY12.2MShares$30.9 Million6.76% of portfolio
About Nuvation Bio Inc.
- Ticker NUVB
- Exchange NYSE
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 217,244,000
- Market Cap $552M
- Description
- Nuvation Bio Inc., a clinical-stage biopharmaceutical company, focuses on the development of therapeutic candidates for oncology. The company's lead product candidate is NUV-422, a small molecule inhibitor targeting cyclin-dependent kinase (CDK)2, CDK4, and CDK6. It is also developing NUV-868, a selective oral small molecule BET inhibitor that e...